Fig 1 - uploaded by Timothy Sakellaridis
Content may be subject to copyright.
Placement of sutures starting off the bronchial anastomosis in a typical right upper lobe sleeve lobectomy of this study. 

Placement of sutures starting off the bronchial anastomosis in a typical right upper lobe sleeve lobectomy of this study. 

Source publication
Article
Full-text available
Pulmonary parenchyma-saving procedures, indicated for central tumours, seem to have better results than pneumonectomy, an alternative procedure. The purpose of this study is to report our experience at our institution with sleeve lobectomy with regard to surgical technique and outcome. We retrospectively reviewed the records of 45 patients who unde...

Contexts in source publication

Context 1
... resection for central bronchial carcinomas is a pulmonary parenchyma-preserving procedure, for which the alternative is pneumonectomy. Sir Clement Price Thomas is credited with the first bronchial sleeve resection performed for a carcinoid tumour in 1947 at the Brompton Hospital in London, UK. Allison, in 1952, performed a sleeve lobectomy for a lung carcinoma and, in 1955, Paulson and Shaw reported the first comprehensive review on the use of these techniques [1—4]. At that time, sleeve resections were considered compromised procedures indicated for patients who could not tolerate the pneumonectomy. Over the ensuing years, the oncological radicality and optimal results of bronchoplastic procedures became evident in comparison to the increased early and late morbidity and mortality of pneumonectomy [5—7]. Faber et al., in 1984, reported their extensive experience and concluded that sleeve lobectomy was a safe procedure, and, when technically feasible, it should be considered the procedure of choice for patients with lung cancer [8]. Recent studies have compared sleeve lobectomy and pneumonectomy in terms of late outcome and morbidity, and even for patients who can tolerate pneumonectomy they have suggested that sleeve lobectomy can achieve adequate curability rates with less mortality and better long-term survival and quality of life [9—12]. We undertook this study to review our experience with sleeve lobectomy, which although minimal in comparison to other centres, has allowed us to develop a minor modification of the technique. We focused on the surgical details and the outcome specific to this challenging, but common, procedure. In an effort to demystify it, we describe a ‘simplified’ operative and postoperative approach accomplished by us over time. During the period of January 2004 and January 2008, 45 patients underwent sleeve lobectomy for non-small-cell lung cancer (NSCLC), with a curative intent, at our general thoracic surgery department, which is considered one of the busiest in our country. We perform approximately 250 lobectomies and 50 pneumonectomies per year. Amongst them, we average 10—12 sleeve lobectomies per year, which constitutes about 4% of our major lung resections. Patients with bronchoplasties other than sleeve lobectomy were excluded from the study. All patients underwent double-lumen endotracheal intubation and posterolateral thoracotomy in the fifth intercostal space. Intra-operative frozen sections of the bronchial resection margins were sent for oncological resection confirmation. Preoperative evaluation included blood tests; chest X-ray; computed tomography (CT) of the chest, abdomen and brain; lung function tests; arterial blood gases and bronchoscopy in all patients. Magnetic resonance imaging, bone scan, Holter monitoring and cardiac stress testing was performed as needed. Mediastinoscopy was performed only in six patients who had mediastinal lymph nodes > 1 cm diameter, as revealed in the chest CT scan, but was negative for N 2 disease in all six patients (the findings were confirmed intra-operatively). In all patients, sleeve resection was decided intra- operatively if the lesion could be radically resected with it, since the majority of the patients included in the study would have been able to tolerate pneumonectomy. Although bronchoscopic findings identified the possible candidates for sleeve lobectomy, operative findings such as intraluminal or extraluminal extension of the tumour to the main bronchus, or the pulmonary artery, as well as presence of positive bronchopulmonary, along the fissure, or hilar lymph nodes, were crucial for the decision, regarding the type of sleeve resection. Radical lymph node dissection was routinely performed, and it was carried out before the bronchial reconstruction. Following double-lumen tube intubation and a standard posterolateral thoracotomy, we proceed with mediastinal lymph node dissection and frozen sections. Lobar vein ligation followed by pulmonary artery branches ligation and completion of the fissures are the usual next steps before bronchial reconstruction. Bronchial anastomosis is performed in an end-to-end fashion with two running, absorbable polyglactine (Vicril, Ethicon, Inc., Somerville, NJ, USA), 3/0 sutures (one for the cartilaginous portion and the other for the membranous portion). Two 3/0 non-absorbable polypropylene (Prolene, Ethicon, Inc., Somerville, NJ, USA) stay sutures are placed first in the proximal and distal end of the cartilaginous portions of the bronchi. Alongside each stay suture, we place and tie each of the two absorbable running 3/0 sutures to be used continuously and circumfer- entially for performing the bronchial anastomosis. As shown in Fig. 1, we begin with the first running suture from the distal end in order to suture and approximate the cartilaginous portion (anteriorly). Then the first running suture is tied to the second on the proximal end, and the membranous portion (posteriorly) is sutured with the second suture, which is then tied to the first suture on the distal end. Two or three additional, interrupted, 3/0 non-absorbable sutures may be required to reinforce the cartilaginous portion. In our case series we did not encounter large-calibre discrepancies where the classic technique with interrupted monofilament sutures would have been more appropriate. Apart from the division of the pulmonary ligament, we did not have to perform a pericardial U-incision around the inferior pulmonary vein in order to keep a tension-free anastomosis. Furthermore, even in patients with bronchovascular anastomoses, we did not use pleural, pericardial or intercostal muscle flap to cover them, because of their doubtful utility. As regards vascular anastomoses, pulmonary artery reconstruction was performed with a 4/0 non-absorbable suture either as an end-to-end anastomosis (in one patient) following proximal and distal occlusion of the pulmonary artery with vascular clamps and resection of the involved segment, or as suturing a bovine pericardial patch (in three patients) following partial clamping with a Satinsky clamp. In the case of total occlusion of the pulmonary artery, systemic anticoagulation with only 2000 units of heparin was given during the operation. Steroids were not given to these patients. Physical therapy and ambulation was started on the first postoperative day, but fibre optic bronchoscopy for aspiration of secretions was performed only as needed (only in seven patients), and not routinely. During the above-mentioned 4-year period, 40 men and five women with a median age of 64 years (range: 24—80 years) underwent sleeve lobectomy. Four patients with a central right upper lobe tumour underwent bronchovascular reconstructive procedures because of pulmonary artery infiltration. One patient had pulmonary artery resection and reconstruction and the remaining three had pulmonary artery patch reconstruction. Indications for sleeve lobectomy included a central bronchial tumour in 42 (93%) patients and a peripheral carcinoma with N 1 (hilar) lymph node involvement in three (7%). In all patients, with both peripheral and central tumours N 1 or N 2 (in two patients), lymph node involvement was found intra-operatively. A bronchial carcinoid tumour was diagnosed in five patients (11%; three women and two men), and it was atypical in one patient of each sex. All five patients with carcinoid tumours had negative regional lymph nodes. The majority of the sleeve resections were performed for tumours of the right hemithorax (91%) and particularly those involving the bronchus of the right upper lobe (67%), as detailed in Table 1. Pathological diagnosis and the TNM (tumour, nodes, metastases) staging as revised in 1997 by the American Joint Committee on Cancer and the International Union against Cancer, of all 45 patients is listed in Table 2 [13]. All 45 patients underwent oncological resections with negative results for malignancy bronchial resection margins. Neither bronchial nor vascular complications occurred with regard to the anastomoses. Postoperative complications occurred in seven patients (15%). They included prolonged (more than 7 days) air leak in three patients with emphyse- matous lungs, lobar atelectasis that needed daily bronchoscopy for aspiration of secretions in three and respiratory failure due to right middle lobe pneumonia in one, who needed intubation and transfer to the intensive care unit. He was a 72 years old patient who underwent a right upper lobe sleeve lobectomy and was suffering from chronic obstructive pulmonary disease treated with bronchodilators, and coronary artery disease treated with angioplasty. Repeated bronchoscopy did not reveal significant kinking or stenosis of the lobar bronchus. The patient died of respiratory failure 3 weeks later, accounting for a 30-day mortality rate of 2%. All others were treated conservatively with success. Interestingly, the patients with prohibitive pneumonectomy respiratory function had an unremarkable postoperative period. None of the 45 patients developed bronchial stricture, bronchopleural fistula or empyema, and none needed re- operation for completion pneumonectomy. All patients with pathological stage greater than I were given adjuvant chemotherapy. The two patients with N 2 disease were also offered chemotherapy plus radiation therapy of the mediastinum. Follow-up period ranged from 1 to 52 months, with a median of 26 months, and was complete for 43 patients (96%). Two patients were lost after 22 and 35 months. Follow- up was based on our clinical records and the information provided by the patients, their relatives or referring physicians. Survival was analysed ...
Context 2
... (Prolene, Ethicon, Inc., Somerville, NJ, USA) stay sutures are placed first in the proximal and distal end of the cartilaginous portions of the bronchi. Alongside each stay suture, we place and tie each of the two absorbable running 3/0 sutures to be used continuously and circumfer- entially for performing the bronchial anastomosis. As shown in Fig. 1, we begin with the first running suture from the distal end in order to suture and approximate the cartilaginous portion (anteriorly). Then the first running suture is tied to the second on the proximal end, and the membranous portion (posteriorly) is sutured with the second suture, which is then tied to the first suture on the distal ...

Similar publications

Article
Reexpansion pulmonary edema is a rare complication that may occur after drainage of pneumothorax or pleural effusion. A number of factors have been identified that increase the risk of developing reexpansion pulmonary edema, and pathophysiologic mechanisms have been postulated. Patients may present with radiographic findings alone or may have signs...
Article
Full-text available
Background The aim of this study is to evaluate the clinical value of a prophylactic minitracheostomy (PMT) in patients undergoing an esophagectomy for esophageal cancer and to clarify the indications for a PMT. Methods Ninety-four patients who underwent right transthoracic esophagectomy for esophageal cancer between January 2009 and December 2013...
Article
Full-text available
Background Congenital scoliosis (CS) may lead to more serious pulmonary complications compared with idiopathic scoliosis after spinal fusion surgery. However, little has been reported about postoperative pulmonary complication events in patients with CS after spinal fusion surgery. Objective To investigate the incidence of and predictive factors o...
Article
Full-text available
Melanoma is a tumor of pigment producing cells melanocytes. Malignant melanoma is associated with a high morbidity and mortality because of its widespread and rapid metastasis. Melanoma commonly metastasizes to lung and secondary metastatic pulmonary melanoma is a well known entity. Metastatic melanoma can present with varied pattern of pulmonary i...

Citations

... Lung resections with bronchovascular reconstruction are invaluable for patients with central tumors, although they do demand more skill than pneumonectomy (6,10). Increasing the proportion of broncho-angioplastic surgery over pneumonectomy may be considered a good surgical practice (5): better results can be achieved for central tumors of the middle and upper lobes by avoiding pneumonectomy and the consequences of major loss of pulmonary parenchyma associated with pneumonectomy. ...
Article
Full-text available
Lobar reimplantation techniques enable the safe resection of lung cancer when pneumonectomy is not desirable or not feasible. We report our experience with this procedure. Patients with difficult to resect upper/middle lobe non-small cell lung cancer were included. In situ reimplantation technique requires the reanastomosis of the pulmonary vein of the healthy lower lobe to the upper lobe stump; bench surgery reimplantation involves the ex vivo surgical treatment of the whole excised lung and subsequent reimplantation of the healthy remnant. Nine patients with upper-middle lobe lung cancer underwent in situ reimplantation, mean age=70.7±4.2 years; 6 patients underwent ex situ resection, mean age=64.3±18.4 years. One obese patient succumbed due to thrombosis of the anastomosed pulmonary vein. One patient developed a stroke. The procedure was in general well-tolerated and enables for curative resection of otherwise unresectable lung cancer. Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.
... In their series of 100 patients, Kutlu and Goldstraw [20] avoided the wrapping of the bronchial anastomosis and concluded that the careful handling of the airway, with the preservation of as much peribronchial tissue as possible, can avoid the need of any tissue flap on the bronchial anastomosis. Konstantinou et al. [21] routinely did not perform any wrapping of the bronchial anastomosis and registered no anastomotic complication. Accordingly, Rea et al. [22] did not find any significant difference in 30-day mortality between patients with or without pedicled flaps. ...
Article
Full-text available
Sleeve resection is the operation of choice in patients with centrally located tumours, in order to avoid a pneumonectomy. Most surgeons protect the bronchial anastomoses with tissue to prevent insufficiencies. The purpose of this study is to report on outcome of unwrapped bronchial anastomoses, especially after neoadjuvant chemo- or chemoradiotherapy. Between 2000 and 2010, 103 patients [59 years (range 16-80), 40 females] underwent bronchial sleeve resections without coverage of the anastomosis with a tissue flap. We retrospectively reviewed the data for morbidity, mortality and survival, especially with regard to the type of resection, neoadjuvant therapy and stage. Sleeve lobectomy was performed in 88, sleeve bilobectomy in 8, sleeve pneumonectomy in 4 and sleeve resection of the main bronchus in 3 patients. Twenty-seven patients had a combined vascular sleeve resection. Neoadjuvant chemotherapy was performed in 20 and radiochemotherapy in 5 patients. Non-small cell lung cancer (NSCLC) was present in 76 patients (squamous cell carcinoma in 44, adenocarcinoma in 24, large cell carcinoma in 6 and mixed cell in 2) and neuroendocrine tumour in 20 and other histological types in 7 patients. The pathologic tumour stage in NSCLC was stage I in 26, stage II in 26, stage IIIA in 16, stage IIIB in 7 and stage IV in 1 patient. There were no anastomotic complications, especially no fistulas. One patient developed narrowing of the intermediate bronchus without need for intervention. Twenty-four patients had early postoperative complications, including 11 surgery-related complications (air leakage, nerve injury, haemothorax or mediastinal emphysema). The 30-day mortality was 3% (one patient died due to heart failure and two with multiorgan failure). The 5-year survival rate was 63% in NSCLC patients and 86% in neuroendocrine tumour patients. Sleeve resection without wrapping the bronchial anastomoses with a tissue flap is safe even in patients who underwent neoadjuvant chemo- or chemoradiotherapy. Therefore, wrapping of the bronchial anastomoses is not routinely mandatory.
... Other long series describing the results of SL or comparing SL and PN results have been published (Table 6) [4,5,7,9,15,16,19,[22][23][24][25]. The series frequently lasted for decades, as broncho-angioplastic techniques were developed in these centres. ...
Article
To study the outcomes of broncho ± angioplastic sleeve lobectomy (SL) versus pneumonectomy (PN), and the PN:SL ratio after an aggressive policy of parenchyma-sparing surgery to improve postoperative complications rate and long-term quality of life (QoL). A prospective study was conducted in 490 patients with non-small cell lung cancer between 2005 and 2009. All patients not suitable for standard lobectomy were scheduled for SL, if possible, or for PN; eight patients with functional impairment were directly scheduled for SL. Of 76 procedures, 21 (4%) were PN and 55 (11%) SL (29 bronchoplastic, seven bronchovascular, seven angioplastic; 11 extended to more than one lobe). There were no surgical, oncological or physiological preoperative differences between the groups. The 5-year PN:SL ratio was 1:2.6 (2005: 1:2.1; 2006: 1:2.6; 2007: 1:3.6; 2008: 1:3; 2009: 1:3.5). SL and PN mortality were 2 (3.6%) and 1 (5%), respectively. Postoperative complications occurred in 18 (32%) SL and 7 (33%) PN patients. pN1 (p = 0.04), vascular reconstruction and upper-left SL were risk factors for postoperative complications of SL (p = 0.03) but were not detected as a mortality risk. Overall 5-year survival was 61% for SL and 31% for PN. Survival at 5 years was significantly higher for SL (p = 0.03, Kaplan-Meier). Age <70 years and SL were positive factors for long-term survival. In multivariate modelling, both remained positive factors. Surviving PN patients experienced significantly greater loss of respiratory function and lower QoL than those who avoided this surgery (preoperative score, PN vs SL: 52 vs 51; 3 months, 41 vs 43; and 6 months, 42 vs 51, p = 0.04). The adjuvant treatment complement was higher in SL at 34 (62%) than at PN 10 (47%). The side effects of this treatment were more frequent in patients with more extirpated parenchyma (p = 0.04). Parenchyma-sparing procedures can reduce the PN rate to less than 10%. A PN:SL index lower than 1:1.5 as a quality standard in a specialised thoracic unit should encourage the use of broncho-angioplastic procedures and improve patient outcomes. Long-term survival, QoL, postoperative lung function test and tolerance of adjuvant therapies are significantly better after SL than PN intervention.
... • Vaciamiento ganglionar del mediastino antes de iniciar la anastomosis, como se ha recomendado en la literatura, para evitar tensión sobre las suturas y disecando los niveles derechos 2, 4, 7, 8, 9 y 10. (1,(4)(5)(6)(7)(8)(9) • Anastomosis del bronquio fuente al intermediario (figura 4), con una sutura de ácido poliglactínico 4-0, con puntos separados y siguiendo la técnica descrita en varias publicaciones. (1,(4)(5)(6)(7)(8)(9) • Se verificó la impermeabilidad al aire de la anastomosis bronquial retirando el tubo a la tráquea y dando asistencia respiratoria con presión positiva hasta alcanzar una presión pico de 25 mm Hg. ...
... • Vaciamiento ganglionar del mediastino antes de iniciar la anastomosis, como se ha recomendado en la literatura, para evitar tensión sobre las suturas y disecando los niveles derechos 2, 4, 7, 8, 9 y 10. (1,(4)(5)(6)(7)(8)(9) • Anastomosis del bronquio fuente al intermediario (figura 4), con una sutura de ácido poliglactínico 4-0, con puntos separados y siguiendo la técnica descrita en varias publicaciones. (1,(4)(5)(6)(7)(8)(9) • Se verificó la impermeabilidad al aire de la anastomosis bronquial retirando el tubo a la tráquea y dando asistencia respiratoria con presión positiva hasta alcanzar una presión pico de 25 mm Hg. ...
Article
Full-text available
Lung bronchoplastic techniques (sleeve lobectomy) were introduced for patients suffering lung cancer who did not tolerate a pneumonectomy, however with time they are now considered an oncologic procedure but there are still some unanswered questions in the literature. The case of a patient with lung cancer who underwent a sleeve lobectomy and a review of the literature are reported in order to answer the questions about the validity of this procedure as an oncologic procedure, the operative risks and the physiologic effects on lung function. Although a bronchial anastomosis is needed, the sleeve lobectomy is a valid oncologic procedure comparable to a pneumonectomy but without the lung functional impact of this operation, and is recommended for patients which anatomically require it.
... Bronchoplastic lobectomies are a viable alternative to pneumonectomy in patients with primary lung cancer Keywords: Lung cancer; Pneumonectomy; Sleeve lobectomy; Bronchoplasty I am most grateful to the editor for the opportunity to comment on the nice experience with bronchoplastic lobectomies published by Dr Konstantinou and his colleagues [1]. The authors work, as they state, in one of the busiest centres of Greece, which performs about 300 resections for lung cancer a year. ...
Article
Background Bronchoplastic procedures have become the gold standard in the lung parenchyma sparing treatment of centrally located bronchopulmonary tumors. Two schools of thought exist when performing a bronchial sleeve resection, those who wrap the anastomosis with a pedicled flap and those who leave the anastomosis unprotected. To the best of our knowledge no studies have been performed comparing these two methods. Methods This study is a retrospective multi-center observational analysis of 90 consecutive patients undergoing bronchial sleeve resections for neoplastic disease between June 2009 and July 2019. Group A (60 patients) underwent bronchial wrapping and group B (30 patients) did not undergo wrapping. Results The only difference between group A, 5 (8.3%) patients, and group B, 10 (33.3%) patients, for general characteristics was the presence of diabetes (p=0.003). There were no differences in surgical, post-operative and follow-up characteristics. There was no statistically significant difference between the two groups [group A 9 (15%) and group B 6 (20%) patients] in terms of anastomotic complications at 1-year (p=0.425). Diabetes was found to be an independent predictive factor for anastomotic complications at 1-year (p=0.035). Number of postoperative complications (p<0.001) was found to be independent risk factors for length of hospital stay. Conclusions We found no differences between the two groups in terms of postoperative complications and length of hospital stay, confirming previous reports that sleeve resections may be performed safely without bronchial wrapping.
Article
Background The optimal treatment of stage I non-small cell lung cancer (NSCLC) is subject to debate. The aim of this study is to compare overall survival and oncological outcomes of lobar resection (LR), sublobar resection (SR) and stereotactic body radiation therapy (SBRT). Materials and Methods A systematic review and meta-analysis of oncological outcomes of propensity matched, comparative and non-comparative cohort studies was performed. Outcomes of interest were overall survival (OS) and disease-free survival (DFS). The inverse variance method and the random effects method for meta-analysis were utilized to assess the pooled estimates. Results A total of 100 studies with patients treated for clinical stage I NSCLC were included. Long-term OS and DFS after LR was superior over SBRT in all comparisons, and for most comparisons SR was superior to SBRT. Non-comparative studies showed superior long-term OS and DFS for both LR and SR over SBRT. Although the papers were heterogeneous and of low quality, results remained essentially the same throughout a large number of stratifications and sensitivity analyses. Conclusion Results of this systematic review and meta-analysis show that LR has superior outcomes compared to SBRT for cI NSCLC. New trials are underway evaluating long-term results of SBRT in potentially operable patients.
Article
Sleeve lobectomy was initially conceived as an alternative to pneumonectomy for patients with low-grade, centrally located lesions and limited cardiopulmonary reserve. Over the last several decades, advances in patient selection criteria and surgical techniques have allowed sleeve lobectomy to evolve from a compromise to pneumonectomy to first line intervention for centrally located lesions of all grades. Although more challenging than pneumonectomy, long-term outcomes and cost-effective measures favor sleeve lobectomy. The use of sleeve lobectomy has been expanded for locally advanced disease, and results remain superior to alternative procedures. Current literature has also shown evidence supporting the use of neoadjuvant treatment and minimally invasive techniques. It is likely that future results will continue to improve making sleeve lobectomy an even more attractive treatment option for qualifying patients.